News

Adding short-course intravenous methylprednisolone to IVIG was associated with faster recovery and reduced neuropathic pain in children with Guillain–Barré syndrome.

In a recent study, children who tapered low-dose atropine before stopping experienced significantly less posttreatment myopia progression and axial elongation vs those who stopped abruptly.

Infants with food protein–induced enterocolitis syndrome showed distinct gut microbial composition.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

Research shows that combining AI models with human expertise significantly boosts diagnostic performance, particularly for rare diseases.

New consensus recommendations outline diagnostic strategies and management considerations for recurrent wheezing in children younger than 3 years.

Lara McKenzie, PhD, emphasizes the urgent need for strong child-resistant packaging to prevent accidental exposures.

Despite a surge in FDA approvals for AI-enabled medical devices, a recent study reveals that devices with pediatric indications are uncommon.

A new study reveals that items such as bleach and detergent packets send a child 5 years or younger to the emergency department every 35 minutes.

Data found that mavacamten significantly reduces cardiac obstruction and improves clinical markers in adolescents with symptomatic obstructive hypertrophic cardiomyopathy.

A study found that children who experience the death of a parent from overdose, homicide, or suicide face increased mortality rates.

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment.

A review of 6 drugs approved by the FDA in Q1 2026, with links to coverage from Contemporary Pediatrics.

Rachel Rosales, MPH, explores how mandatory reporting and integrated care models can address the structural barriers preventing consistent behavioral health screenings.

Pediatric nutrition counseling transforms conversations by focusing on inclusion, behaviors, and barriers, fostering meaningful change for families.

Pediatric visits make nutrition doable: quick questions, budget-smart swaps, myth-busting advice, and family meals that boost kids’ growth.

A review of 4 drugs to be discussed by the US FDA during Q2 2026, with links to coverage from MJH Life Sciences publications.

As we step into Q2 2026, take a look back at our top video interviews and packages of Q1.

Perry Rosen, MD, offers essential guidance for clinicians on prevention and emergency management of pediatric nicotine poisoning.

Get caught up with Contemporary Pediatrics. This list helps you navigate our top stories from the week, all in one place.

A 7460% increase in pediatric inhalation exposures since 2016 highlights the need for child-resistant designs and updated parental guidance.

The FDA has updated its approval for 1-mg epinephrine nasal spray, removing the age limit to allow all patients weighing at least 33 lb to access the treatment.

Linda Stein Gold, MD, discusses the promising safety and efficacy of tapinarof cream, 1%, as a nonsteroidal treatment for pediatric patients with atopic dermatitis.

Jennifer Hoffmann, MD, MS, discusses the high rates of overtriage in children with behavioral health symptoms and the need for more objective triage tools.

Researchers found no significant differences in laboratory abnormalities among children with PANS, OCD, and tic disorders.

A recent study found no significant correlation between childhood atopic dermatitis and an increase in cardiovascular risk markers.

This new once-weekly intravenous therapy aims to treat the neurologic manifestations of Hunter syndrome in young children.

Margeaux Naughton, MD, discusses the Pediatric Psychiatry Colocalized Consult Clinic model, a strategic approach to improve mental health access and provider training.